Orestis Argyros

678 total citations
21 papers, 536 citations indexed

About

Orestis Argyros is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Orestis Argyros has authored 21 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Genetics and 3 papers in Infectious Diseases. Recurrent topics in Orestis Argyros's work include Virus-based gene therapy research (12 papers), RNA Interference and Gene Delivery (10 papers) and CRISPR and Genetic Engineering (5 papers). Orestis Argyros is often cited by papers focused on Virus-based gene therapy research (12 papers), RNA Interference and Gene Delivery (10 papers) and CRISPR and Genetic Engineering (5 papers). Orestis Argyros collaborates with scholars based in United Kingdom, Greece and Germany. Orestis Argyros's co-authors include Richard P. Harbottle, Suet Ping Wong, Charles Coutelle, Steven J. Howe, Andrew D. Miller, Constantin Tamvakopoulos, Maya Thanou, Simon N. Waddington, Marcello Niceta and Suet‐Ping Wong and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Controlled Release.

In The Last Decade

Orestis Argyros

20 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Orestis Argyros United Kingdom 15 406 215 57 52 40 21 536
Simon S. Briggs United Kingdom 12 660 1.6× 369 1.7× 99 1.7× 33 0.6× 69 1.7× 15 775
Mary Prieve United States 7 497 1.2× 100 0.5× 53 0.9× 47 0.9× 75 1.9× 11 629
Jere T. Pikkarainen Finland 12 368 0.9× 174 0.8× 107 1.9× 52 1.0× 137 3.4× 16 594
Sang-oh Han United States 14 648 1.6× 309 1.4× 77 1.4× 44 0.8× 73 1.8× 27 896
Hirokuni Uchida Japan 9 614 1.5× 182 0.8× 28 0.5× 49 0.9× 143 3.6× 10 757
Christof Maucksch Germany 11 253 0.6× 90 0.4× 31 0.5× 36 0.7× 47 1.2× 20 436
Cristine Gonçalves France 15 640 1.6× 243 1.1× 44 0.8× 69 1.3× 117 2.9× 26 793
Thierry Arnould France 14 820 2.0× 264 1.2× 75 1.3× 19 0.4× 90 2.3× 21 943
Mathieu Mével France 19 763 1.9× 234 1.1× 47 0.8× 138 2.7× 112 2.8× 30 935
Mohamed Mashal Spain 13 392 1.0× 105 0.5× 22 0.4× 31 0.6× 87 2.2× 21 564

Countries citing papers authored by Orestis Argyros

Since Specialization
Citations

This map shows the geographic impact of Orestis Argyros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orestis Argyros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orestis Argyros more than expected).

Fields of papers citing papers by Orestis Argyros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orestis Argyros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orestis Argyros. The network helps show where Orestis Argyros may publish in the future.

Co-authorship network of co-authors of Orestis Argyros

This figure shows the co-authorship network connecting the top 25 collaborators of Orestis Argyros. A scholar is included among the top collaborators of Orestis Argyros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orestis Argyros. Orestis Argyros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Argyros, Orestis, Konstantinos C. Tsolis, George Βertsias, et al.. (2026). DNA damage in macrophages drives immune autoreactivity via nuclear antigen presentation. Nature Aging. 6(2). 393–413.
2.
Argyros, Orestis, et al.. (2021). Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer. Frontiers in Oncology. 11. 608201–608201. 15 indexed citations
3.
Lougiakis, Nikolaos, Thomas Evangelidis, Ioannis K. Kostakis, et al.. (2017). Discovery of New Aminosubstituted Pyrrolopyrimidines with Antiproliferative Activity Against Breast Cancer Cells and Investigation of their Effect Towards the PI3Kα Enzyme. Anti-Cancer Agents in Medicinal Chemistry. 17(7). 990–1002. 3 indexed citations
4.
Karampelas, Theodoros, et al.. (2017). Gemcitabine Based Peptide Conjugate with Improved Metabolic Properties and Dual Mode of Efficacy. Molecular Pharmaceutics. 14(3). 674–685. 20 indexed citations
5.
Argyros, Orestis, Theodoros Karampelas, Aimilia Varela, et al.. (2017). Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule. Oncotarget. 8(23). 37250–37262. 9 indexed citations
6.
Argyros, Orestis, Nikolaos Lougiakis, Catherine P. Raptopoulou, et al.. (2016). Design and synthesis of novel 7-aminosubstituted pyrido[2,3-b]pyrazines exhibiting anti-breast cancer activity. European Journal of Medicinal Chemistry. 126. 954–968. 14 indexed citations
7.
Argyros, Orestis, Theodoros Karampelas, Aimilia Varela, et al.. (2015). Peptide–Drug Conjugate GnRH–Sunitinib Targets Angiogenesis Selectively at the Site of Action to Inhibit Tumor Growth. Cancer Research. 76(5). 1181–1192. 24 indexed citations
8.
Wong, Suet Ping, Orestis Argyros, & Richard P. Harbottle. (2014). Sustained Expression from DNA Vectors. Advances in genetics. 89. 113–152. 22 indexed citations
9.
Drake, Christopher R., Abderrahim Aissaoui, Orestis Argyros, et al.. (2013). Examination of the effect of increasing the number of intra-disulfide amino functional groups on the performance of small molecule cyclic polyamine disulfide vectors. Journal of Controlled Release. 171(1). 81–90. 25 indexed citations
10.
Argyros, Orestis, Suet Ping Wong, Kate H.C. Gowers, & Richard P. Harbottle. (2012). Genetic Modification of Cancer Cells Using Non-Viral, Episomal S/MAR Vectors for In Vivo Tumour Modelling. PLoS ONE. 7(10). e47920–e47920. 11 indexed citations
11.
Wong, Suet Ping, Orestis Argyros, & Richard P. Harbottle. (2012). Vector Systems for Prenatal Gene Therapy: Principles of Non-viral Vector Design and Production. Methods in molecular biology. 891. 133–167. 20 indexed citations
12.
Argyros, Orestis, Suet Ping Wong, Oleg Tolmachov, et al.. (2011). Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver. Journal of Molecular Medicine. 89(5). 515–529. 47 indexed citations
13.
Argyros, Orestis, Suet‐Ping Wong, & Richard P. Harbottle. (2011). Non-viral episomal modification of cells using S/MAR elements. Expert Opinion on Biological Therapy. 11(9). 1177–1191. 18 indexed citations
14.
Haase, Rudolf, Orestis Argyros, Suet‐Ping Wong, et al.. (2010). pEPito: a significantly improved non-viral episomal expression vector for mammalian cells. BMC Biotechnology. 10(1). 20–20. 61 indexed citations
15.
Wong, Suet Ping, Orestis Argyros, Steven J. Howe, & Richard P. Harbottle. (2010). Systemic gene transfer of polyethylenimine (PEI)–plasmid DNA complexes to neonatal mice. Journal of Controlled Release. 150(3). 298–306. 26 indexed citations
16.
Wong, Suet Ping, Orestis Argyros, Charles Coutelle, & Richard P. Harbottle. (2010). Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage. Gene Therapy. 18(1). 82–87. 33 indexed citations
17.
Drake, Christopher R., Abderrahim Aissaoui, Orestis Argyros, et al.. (2010). Bioresponsive Small Molecule Polyamines as Noncytotoxic Alternative to Polyethylenimine. Molecular Pharmaceutics. 7(6). 2040–2055. 19 indexed citations
18.
Green, Mark, Philip D. Howes, Catherine C. Berry, Orestis Argyros, & Maya Thanou. (2009). Simple conjugated polymer nanoparticles as biological labels. Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences. 465(2109). 2751–2759. 40 indexed citations
19.
Wong, Suet Ping, Orestis Argyros, Charles Coutelle, & Richard P. Harbottle. (2009). Strategies for the episomal modification of cells.. PubMed. 11(4). 433–41. 11 indexed citations
20.
Argyros, Orestis, Suet Ping Wong, Marcello Niceta, et al.. (2008). Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector. Gene Therapy. 15(24). 1593–1605. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon S. Briggs Breakdown of academic impact, for papers by Mary Prieve Breakdown of academic impact, for papers by Jere T. Pikkarainen Breakdown of academic impact, for papers by Sang-oh Han Breakdown of academic impact, for papers by Hirokuni Uchida Breakdown of academic impact, for papers by Christof Maucksch Breakdown of academic impact, for papers by Cristine Gonçalves Breakdown of academic impact, for papers by Thierry Arnould Breakdown of academic impact, for papers by Mathieu Mével Breakdown of academic impact, for papers by Mohamed Mashal
Rankless by CCL
2026